World Health Organization Raises Concern Over Acute Shortage of Weight-Loss Jabs
Fewer than 10% of individuals who could benefit from obesity jabs such as Wegovy are able to get them, states the World Health Organization as it publishes its inaugural guidance on the drugs.
Given in excess of 1,000,000,000 people worldwide currently living with obesity, it is advocating for more widespread and fairer availability to these injectable treatments.
Based on projections, more than two billion will be obese by 2030 if no action is taken.
"The latest guidelines recognises that excess weight is a lifelong illness that can be managed with comprehensive and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and supply-chain constraints are significant hurdles to broad access to the injections that can aid individuals in losing considerable body mass, notes the organization.
Weight-Loss Drug Supply Crisis
Even under the current most optimistic scenario, the production of these medications would only suffice for around 100 million people – fewer than 10% of those who need them, as stated by the WHO.
The guideline calls on nations and manufacturers to widen availability, via approaches such as voluntary licensing.
A patent on a key compound – the main ingredient of a leading brand – is set to lapse in several nations in 2026.
How Obesity Jabs Operate
The injections replicate a biological compound to reduce digestion speed, reduce hunger and increase feelings of fullness so people reduce food intake.
Individuals commonly start to lose weight within a few weeks of starting on the weekly injections.
Studies suggests users may regain a significant portion within a year of halting the drug, when their usual hunger come back.
To be above a healthy weight increases your likelihood for contracting medical conditions, such as diabetes, heart disease, stroke, and specific malignancies.
Obesity affects individuals in every country and was responsible for 3.7 million deaths worldwide in 2024, according to the health agency.
